Risk assessment in pulmonary arterial hypertension

Marius M. Hoeper, David Pittrow, Christian Opitz, J. Simon R. Gibbs, Stephan Rosenkranz, Ekkehard Grünig, Karen M. Olsson, Doerte Huscher

Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017
Journal Issue: March
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marius M. Hoeper, David Pittrow, Christian Opitz, J. Simon R. Gibbs, Stephan Rosenkranz, Ekkehard Grünig, Karen M. Olsson, Doerte Huscher. Risk assessment in pulmonary arterial hypertension. Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Risk stratification and medical therapy of pulmonary arterial hypertension
Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018
Year: 2019



Risk stratification in pulmonary arterial hypertension (PAH)
Source: International Congress 2018 – New trends in the management of pulmonary hypertension
Year: 2018


Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018




Imaging risk in pulmonary arterial hypertension
Source: Eur Respir J, 56 (3) 2002313; 10.1183/13993003.02313-2020
Year: 2020



Trends in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 7-12
Year: 2009

Pregnancy in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 431-437
Year: 2016



Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018



Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Year: 2017



Prognosis in pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 971-972
Year: 2011


Pregnancy and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Pulmonary arterial hypertension
Source: Eur Respir Monogr 2013; 62: 70-84
Year: 2013


Pulmonary arterial hypertension
Source: Eur Respir Monogr 2014; 66: 232-246
Year: 2014


Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=126
Year: 2005

Pulmonary arterial hypertension
Source: ISSN=ISSN 1810-6838, ISBN=, page=397
Year: 2007

Pulmonary arterial hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Pulmonary arterial hypertension
Source: Breathe 2010; 6: 377-380
Year: 2010

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014